Russell Investments Group’s Lyra Therapeutics LYRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$14.3K Buy
+1,594
New +$14.3K ﹤0.01% 3260
2020
Q4
Sell
-274
Closed -$153K 3131
2020
Q3
$153K Buy
+274
New +$153K ﹤0.01% 2878